Fresenius Kabi

Fresenius Kabi is the leader in infusion therapy and clinical nutrition in Europe and in its most important countries of Latin America and Asia Pacific. Within I.V. generic drugs, Fresenius Kabi counts among the leading suppliers in the U.S. market.

We are focused on the therapy and care of critically and chronically ill patients in and outside the hospital. Fresenius Kabi has more than 30,000 employees worldwide and a global network of around 55 sales organizations and more than 55 production sites. Fresenius Kabi is a 100% subsidiary of the health care group Fresenius SE with more than 130, 000 employees.  

"Caring for life"

Fresenius Kabi brings people together from all over the world with different cultural backgrounds working together as a team. With our commitment to improve patients’ quality of life, we take care of our customers’ specific needs throughout the world.

Our products ensure an efficient clinical outcome, reduce suffering and enhance a patient’s quality of life.

Our “caring for life” claim reflects our strong dedication and efforts to support the treatment and care of patients worldwide. We are committed to focusing on what matters most in health care – improving a patient’s quality of life.

Fresenius Kabi in Sweden

In Sweden we are 900 employees working within two manufacturing plants, the production units in Uppsala and in Brunna, specialised in producing parenteral nutrition and raw mateial. Furthermore, our employees are striving to meet the expectations from the market and our customers in their roles as Sales Representatives, Engineers, within R & D, within the Quality Assurance department , IT, Finance and HR. 

The mangement of  Global Operaions Clinical Nutrition & Pharma is located in Uppsala as well as the Market Company in Sweden.